Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.
American Journal of Nephrology|June 13, 2009
The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristicsH J Lambers Heerspink, R Agarwal, D W Coyne, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.
Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.
The British Journal of Dermatology|February 9, 2011
Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasisK M P Rodrigues, M P Oliveira, A C Maretti-Mira, et al.
Pediatric Transplantation|March 21, 2012
The impact of perioperative transfusion of blood products on survival after pediatric liver transplantationM Nacoti, S Cazzaniga, F Lorusso, et al.
Kidney International|September 5, 2001
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseaseT H Jafar, P C Stark, C H Schmid, et al.
Pageof 43